低聚果糖与低聚半乳糖在婴幼儿配方乳粉中的精准化应用

doi:10.12377/1671-4393.21.07.20

摘要/Abstract

摘要： 母乳是婴幼儿营养配方的金标准,而低聚糖是母乳重要的活性成分。我国母乳喂养婴幼儿平均每天摄入3.5~6.4 g母乳低聚糖,而婴幼儿配方乳粉（以下简称“婴配粉”）喂养婴幼儿平均每天摄入的低聚果糖与低聚半乳糖仅0.6~3.0 g。为精准模拟母乳低聚糖的作用,低聚果糖与低聚半乳糖的含量至关重要。因此,低聚果糖与低聚半乳糖在婴配粉中的添加量有必要适当提高。

关键词: 母乳低聚糖, 低聚果糖, 低聚半乳糖, 婴幼儿配方乳粉

Abstract: Breast milk is the gold standard of infant nutrition,while oligosaccharides are an important active ingredient in breast milk.Breastfed infants in China consume an average of 3.5~6.4g of human milk oligosaccharides per day,while their formula-fed counterparts only consume an average of 0.6~3.0g of fructo-oligosaccharides and galacto-oligosaccharides per day.To accurately mimic the effects of human milk oligosaccharides,the level of fructo-oligosaccharides and galacto-oligosaccharides is of vital importance.Therefore, the addition level of fructo-oligosaccharides and galacto-oligosaccharides in infant formula needs to be appropriately increased.

Key words: human milk oligosaccharides, fructo-oligosaccharides, galacto-oligosaccharides, infant formula

王炜宏, 杨新球. 低聚果糖与低聚半乳糖在婴幼儿配方乳粉中的精准化应用[J]. 中国乳业, 2021, 0(7): 102-108.

WANG Weihong, YANG Xinqiu. Precise Application of Fructo-oligosaccharides and Galacto-oligosaccharides in Infant Formula[J]. China Dairy, 2021, 0(7): 102-108.

参考文献

[1] Petersen H, Nomayo A, Zelenka R, et al.Adequacy and safety of alpha-lactalbumin-enriched low-protein infant formula: A randomized controlled trial[J]. Nutrition, 2020, 74: 110728.
[2] 牛仙,邓泽元,王佳琦,等. 国内外婴儿配方奶粉中营养成分的比较与分析[J]. 中国乳品工业,2021,49(2):28-34,46.
[3] Astolfi M L, Marconi E, Protano C, et al.Optimization and validation of a fast digestion method for the determination of major and trace elements in breast milk by ICP-MS[J]. Analytica Chimica Acta, 2018, 1040:49-62.
[4] 项云仙. 影响母乳喂养的因素及对策[J]. 中国农村卫生事业管理,2018,38(4): 523-525.
[5] De leoz m L, Kalanetra K M, Bokulich N A, et al. Human milk glycomics and gut microbial genomics in infant feces show a correlation between human milk oligosaccharides and gut microbiota: A proof-of-concept study[J]. Journal of Proteome Research, 2015, 14(1): 491-502.
[6] Wicinski M, Sawicka E, Gebalski J, et al.Human milk oligosaccharides: health benefits, potential applications in infant formulas, and pharmacology[J]. Nutrients, 2020, 12(1).
[7] 袁慧芝,荀一萍,蒲晓璐,等.母乳低聚糖与婴儿肠道菌群相关性研究进展[J].食品科学. https://kns.cnki.net/kcms/detail/11.2206.TS.20200924.1432.034.html.
[8] Ward RE, Ninonuevo M, Mills D A, et al.In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri[J]. Applied and Environmental Microbiology, 2006, 72(6): 4497-4499.
[9] Underwood M A, Gaerlan S C, De leoz M L, et al. Human milk oligosaccharides in premature infants: absorption, excretion, and influence on the intestinal microbiota[J]. Pediatric Research, 2015, 78(6): 670-677.
[10] Bode L.Human milk oligosaccharides: every baby needs a sugar mama[J]. Glycobiology, 2012, 22(9): 1147-1162.
[11] Ruiz-Palacios G M, Cervantes L E, Ramos P, et al. Campylobacter jejuni binds intestinal H(O) antigen(fucα1,2galβ1,4glcnac), and fucosyloligosaccharides of human milk inhibit its binding and infection[J]. Journal of Biological Chemistry, 2003, 278(16): 14112-14120.
[12] Newburg D S, Ruiz-Palacios G M, Morrow A L. Human milk glycans protect infants against enteric pathogens. Annual Review of Nutrition, 2005, 25: 37-58.
[13] Kuntz S, Kunz C, Rudloff S.Oligosaccharides from human milk induce growth arrest via G2/M by influencing growth-related cell cycle genes in intestinal epithelial cells. British Journal of Nutrition, 2009, 101(9): 1306-1315.
[14] Eiwegger T, Stahl B, Haidl P, et al.Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatric Allergy and Immunology, 2010, 21(8): 1179-1188.
[15] Neu J, Walker WA.Necrotizing enterocolitis[J]. The New England Journal of Medicine, 2011, 364: 255-264.
[16] Holman RC, Stoll BJ, Curns AT, et al.Necrotising enterocolitis hospitalisations among neonates in the United States[J]. Paediatric & Perinatal Epidemiology, 2010, 20(6): 498-506.
[17] Holman RC, Stoll BJ, Clarke MJ, et al.The epidemiology of necrotizing enterocolitis infant mortality in the United States[J]. American Journal of Public Health, 1998, 87(12): 2026-2031.
[18] Rees CM, Pierro A, Eaton S.Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis[J]. Archives of Disease in Childhood Fetal & Neonatal Edition, 2007, 92(3): F193-F198.
[19] Sisk PM, Lovelady CA, Dillard RG, et al.Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants[J]. Journal of Perinatology, 2007, 27(7): 428-433.
[20] Lucas A, Morley R, Cole T J, et al.Breast milk and subsequent intelligence quotient in children born preterm[J]. Lancet, 1992, 339:261-264.
[21] Kunz C, Rudloff S, Schad W, et al.Lactose-derived oligosaccharides in the milk of elephants: comparison with human milk[J]. British Journal of Nutrition, 1999, 82(5): 391-399.
[22] Wang J, Wang J Q, Bu D P, et al.Application of near-infrared spectroscopy to quality detection of milk and its products[J]. Spectroscopy and Spectral Analysis, 2009, 29(5): 1281-1285.
[23] German J, Freeman S, Lebrilla C, et al.Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria[J]. Nestle Nutrition Workshop Ser Pediatr Program, 2008, 62: 205-222.
[24] Smilowitz JT, Lebrilla CB, Mills DA, et al.Breast milk oligosaccharides: structure-function relationships in the neonate[J]. Annual Review of Nutrition, 2014, 34(1): 143-169.
[25] Kunz C, Meyer C, Collado MC, et al.Influence of gestational age, secretor and Lewis blood group status on the oligosaccharide content of human milk[J]. Journal of Pediatric Gastroenterology & Nutrition, 2017, 64(5):789-798.
[26] Donovan S M, Comstock S S.Human milk oligosaccharides influence neonatal mucosal and systemic immunity[J]. Annals of Nutrition & Metabolism, 2016, 69(Suppl 2):42-51.
[27] 魏远安,张丽君,郑惠玲,等. 中国母乳低聚糖的研究进展和现状[J]. 乳业科学与技术,2016,39(3):33-38.
[28] Vandenplas Y, Berger B, Carnielli V P, et al.Human milk oligosaccharides: 2-Fucosyllactose(2-FL)and Lacto-N-Neotetraose(LNnT)in infant formula[J]. Nutrients, 2018, 10(9):1161-1172.
[29] Goudoever V, J. B, Schols, et al. Human milk oligosaccharides in colostrum and mature milk of Chinese mothers: Lewis positive secretor subgroups[J]. Journal of Agricultural and Food Chemistry, 2018, 66(27): 7036-7043.
[30] Rockova S, Rada V, Nevoral J, et al.Inter-species differences in the growth of bifidobacteria cultured on human milk oligosaccharides[J]. Folia Microbiol, 2012, 57(4): 321-324.
[31] Wu J, Wu S, Huo J, et al. Systematic characterization and longitudinal study reveal distinguishing features of human milk oligosaccharides in China[J]. Current Developments in Nutrition, 2020,4(8): nzaa113.
[32] Bode L.Human milk oligosaccharides: next-generation functions and questions[J]. Nestlé Nutrition Institute Workshop Series, 2019, 90: 191-201.
[33] Nakamura T, Kawase H, Kimura K, et al.Concentrations of sialyloligosaccharides in bovine colostrum and milk during the prepartum and early lactation[J]. Journal of Dairy Science, 2003, 86(4): 1315-1320.
[34] 王艳菲,公丕民,张兰威. 母乳低聚糖及其在婴幼儿配方乳粉中的替代品研究进展[J]. 乳业科学与技术,2020,43,201(1):32-39.
[35] Gibson G R, Hutkins R, Sanders M E, et al.The International Scientific Association for Probiotics and Prebiotics(ISAPP)consensus statement on the definition and scope of prebiotics[J]. Nature Reviews. Gastroenterology & Hepatology, 2017, 14(8):491-502.
[36] Kapiki A, Costalos C, Oikonomidou C, et al.The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants[J]. Early Human Development, 2007, 83: 335-339.
[37] FanaroS, Marten B, Bagna R, et al. Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study[J]. Journal of Pediatric Gastroenterology & Nutrition, 2009, 48(1): 82-88.
[38] Moro G.A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age[J]. Archives of Disease in Childhood, 2006, 91(10): 814-819.
[39] Arslanoglu S, Moro G E, Schmitt J, et al.Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life[J]. Journal of Nutrition, 2008, 138(6):1091-1095.
[40] Arslanoglu S, Moro G E, Boehm G.Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life[J]. Journal of Nutrition, 2007, 137(11): 2420-2424.
[41] Skã³Rka A, PieåCik-Lech M, KoåOdziej M, et al. Infant formulae supplemented with prebiotics: are they better than unsupplemented formulae? an updated systematic review[J]. British Journal Of Nutrition, 2018: 1-16.
[42] Marcello G, Elvira V, Dario G, et al.Prebiotic effect of an infant formula supplemented with galacto-oligosaccharides: randomized multicenter trial[J]. Journal of the American College of Nutrition, 2014, 33(5):385-393.
[43] Ivakhnenko O S, Nyankovskyy S L.Effect of the specific infant formula mixture of oligosaccharides on local immunity and development of allergic and infectious disease in young children: randomized study[J]. Pediatria Polska, 2013, 88(5): 398-404.
[44] 龙晓蕾,刘美佟,尹晓晨,等.含益生元配方奶粉对婴儿肠道微生态的影响[J]. 实用预防医学,2020,27(8):954-956.
[45] 吴江,蒋永江,柴灵莺,等. 含低聚半乳糖+低聚果糖配方奶对婴儿粪便性状及有益菌水平的影响[J]. 临床儿科杂志,2017,35(11):826-831.
[46] Euler A R, Mitchell D K, Kline R, et al.Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk.[J]. Journal of Pediatric Gastroenterology and Nutrition, 2005, 40(2): 157-164.
[47] Brunser O, Figueroa G, Gotteland M, et al.Effects of probiotic or prebiotic supplemented milk formulas on fecal microbiota composition of infants[J]. Asia Pacific Journal of Clinical Nutrition, 2006, 15(3): 368-376.
[48] Takumi T, Yoshihiro K, Toshio T, et al.1-kestose, the smallest fructooligosaccharide component, which efficiently stimulates Faecalibacterium prausnitzii as well as Bifidobacteria in humans[J]. Foods, 2018, 7(9): 140-150.
[49] Bakker-Zierikzee A M, Alles M S, Jan K, et al. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life[J]. British Journal of Nutrition, 2005, 94(5):783-790.
[50] Bakker-Zierikzee AM, Tol E A, Kroes H, et al.Faecal SIgA secretion in infants fed on pre- or probiotic infant formula[J]. Pediatr Allergy Immunol, 2006, 17: 134-140.
[51] Brandtzaeg P.Role of secretory antibodies in the defence against infections. International Journal of Medical Microbiology, 2003, 293(1):3-15.
[52] Knol J, Scholtens P, Kafka C, et al.Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants[J]. Journal of Pediatric Gastroenterology And Nutrition, 2005, 40(1):36-42.
[53] Alfonso R H, Kelly M, Hetty B, et al. Gastrointestinal tolerance, growth and safety of a partly fermented formula with specific prebiotics in healthy infants: a double-blind, randomized, controlled trial[J].Nutrients, 2009, 11, 1530. https://doi.org/10.3390/nu11071530
[54] Da Sopoulou M, Briana D D, Boutsikou T, et al.Motilin and gastrin secretion and lipid profile in preterm neonates following prebiotics supplementation[J]. Journal of Parenteral and Enteral Nutrition, 2015, 39(3):359-368.
[55] Schouten B, Esch B, Kormelink T G, et al.Non‐digestible oligosaccharides reduce immunoglobulin free light‐chain concentrations in infants at risk for allergy[J]. Pediatric Allergy and Immunology, 2011, 22(5): 537-542.
[56] Boehm G, Lidestri M, Casetta P, et al.Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecalbifidobacteria in preterm infants[J]. Archives of Disease in Childhood - Fetal and Neonatal Edition, 2002, 86(3):178-181.
[57] Mannetje A', Coakley J, Bridgen P, et al. Estimated infant intake of persistent organic pollutants through breast milk in New Zealand[J]. New Zealand Medical Journal, 2014, 127(1401):56-68.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed